Search – Page 4 – Indianapolis Business Journal

Home » Search

Articles

City-County Council approves $7 million tax abatement for Eli Lilly

March 19, 2019 | Hayleigh Colombo

The council voted 19-6 to approve Lilly’s request, which is tied to the firm’s pledge to spend $91 million on a building at its Lilly Technology Center that will house the company’s biosynthetic human insulin production operations

Eli Lilly negotiated its largest deal ever at breakneck speed

February 7, 2019

When the Indianapolis-based drug giant made its initial offer Dec. 20, it said it wanted to seal the deal before the J.P. Morgan Healthcare Conference, which ran Jan. 7-10 in San Francisco.

Trump Medicare plan targets drugs from Eli Lilly, others

November 27, 2018

Makers of antidepressants and antipsychotics like Indianapolis-based Eli Lilly and Co., AstraZeneca, Pfizer, Allergan, Bausch Health and Otsuka Holdings might face new challenges and may be deterred from price hikes.

Rising fear among Asians leads Eli Lilly to rethink employee groups

November 24, 2018

New employees at Eli Lilly and Co. get a letter encouraging them to join one of the pharmaceutical firm’s affinity groups. There’s one for African Americans, one for Latino employees—and four for Asians.

Eli Lilly considering sale of China assets to raise cash

November 16, 2018

Indianapolis-based Lilly is working with advisers to gauge interest in selling off a selection of older drugs for antibiotics and central nervous system diseases in China.

Eli Lilly partner urges investors to look beyond biotech turmoil

November 1, 2018

Look at the future prospects, not the losses, says the CEO of a newly listed Chinese biotech company that’s developing anti-cancer drugs with Indianapolis-based Eli Lilly and Co.

Migraine drug from Eli Lilly approved by FDA

September 28, 2018

Eli Lilly and Co. received clearance Thursday from U.S. regulators for a new migraine drug that will be the third in a promising class of therapies for patients who suffer from the recurrent, painful headaches.

Franklin College lands $2M gift from former Eli Lilly executive

September 6, 2018

The money will be used to create a super endowment that will help fund future projects in perpetuity, Franklin College President Thomas Minar said.

Eli Lilly’s animal-health business files for initial public offering

August 3, 2018

Elanco Animal Health Inc. could see a market value of as much as $20 billion, according to Bloomberg Intelligence. At that valuation, a share sale could raise as much as $5 billion.

Another experimental Alzheimer’s drug fails as Eli Lilly, Astra halt tests

June 12, 2018

An independent data-monitoring committee found that the medicine, lanabecestat, was unlikely to meet the goals of the studies, one for early Alzheimer’s and the other for mild dementia related to the disease.

Eli Lilly to spend up to $575M to reacquire oncology compound it discovered

May 14, 2018

The Indianapolis-based drugmaker said the compound, called AK-01, could be useful for multiple types of tumors.

UPDATE: Eli Lilly buying immuno-oncology company for $1.6 billion

May 10, 2018

The Indianapolis-based pharmaceutical giant said it plans to acquire ARMO BioSciences Inc., which is working on treatments that activate the immune system of cancer patients to recognize and eradicate tumors.

Eli Lilly’s next big push likely to come in pain treatments

April 30, 2018

The Indianapolis-based drugmaker has several pain medications in the pipeline, including potential treatments for migraine headaches, arthritis and chronic back pain.

Private equity firms mull bids for Eli Lilly’s Elanco unit

April 25, 2018

The Indianapolis pharmaceutical giant is evaluating whether to keep the division, which makes animal-health products, or sell it or take it public. An analyst said it might fetch $16 billion.

Eli Lilly hikes forecast after better-than-expected first quarter

April 24, 2018

Indianapolis-based Eli Lilly and Co. on Tuesday reported quarterly revenue and adjusted earnings that exceeded analyst forecasts.

Ricks makes $14.4 million in first year as Eli Lilly CEO

March 1, 2018

Eli Lilly CEO David Ricks’ first year in charge was marked by a wave of activity, including a huge corporate restructuring. The company’s stock price climbed about 6.2 percent during the year.

British Supreme Court rules in Eli Lilly’s favor in drug dispute

July 7, 2017

Britain's Supreme Court has ruled in favor of Eli Lilly and Co. in a patent dispute with generic drugmaker Actavis over Lilly's Alimta cancer treatment.

Eli Lilly chasing psoriasis jackpot with Taltz

March 16, 2017

Taltz, which hit the market last year, is taking on an armful of older treatments, including creams, lotions, pills and injectables, such as Amgen’s Enbrel and AbbVie’s Humira.

Why former Mayor Peterson is stepping down from drugmaker Eli Lilly

March 6, 2017

Getting elected mayor requires fine-tuned political instincts. Sometimes, those instincts say it’s time to leave a high-level job at the biggest company in town.

Eli Lilly aims to cut 200 R&D jobs

February 6, 2017

The Indianapolis-based drugmaker has offered many of its research and development employees a compensation package if they leave the company.

« Previous 1 2 3 4 5 6 … 221 Next »

Search Results

4,409 results for '\"eli lilly\"'